Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

Market Cap	11.04B
Revenue (ttm)	3.74B
Net Income (ttm)	534.00M
Shares Out	431.05M
EPS (ttm)	1.24
PE Ratio	20.64
Forward PE	16.91
Dividend	0.40 (1.56%)
Ex-Dividend Date	Jul 26, 2024

Volume	3,607,300
Average Volume	8,707,793
Open	25.85
Previous Close	25.81
Day's Range	25.52 - 25.94
52-Week Range	21.33 - 31.18
Beta	0.56
RSI	47.47
Earnings Date	Aug 22, 2025

About SHA:600993

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the manufacturing and sale of Chinese and Western medicines primarily in China. The company provides functional cosmetics, such as eye care, eye daily necessities, facial and body cleaning, and care products; functional care products include infant paper, infant skin care, feminine products, etc.; functional foods, including moisturizing the intestines, promoting digestion, and nourishing the kidneys. It also offers foundation and dietary supplements; medical ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1582
• Employees: 2,882
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600993

Financial Performance

In 2024, SHA:600993's revenue was 3.73 billion, an increase of 18.85% compared to the previous year's 3.14 billion. Earnings were 528.09 million, an increase of 19.14%.